Suggest OTCs for Seasonal Allergies Instead of Montelukast

New boxed warnings for montelukast (Singulair) will raise questions about managing seasonal spring ramps up.

Cases of mental health effects (depression, suicide, etc) are still being reported with montelukast...despite prior precautions.

FDA now says that montelukast’s benefits may NOT outweigh risks...especially for most patients with “hay fever.”

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote